Seek revenue guidance for FY23 downgraded by 1.2% and shares fall by 5%

Nick Sundich Nick Sundich, April 4, 2023

Barely 6 weeks after it was issued, Seek’s revenue guidance for FY23 was cut. This led to a 5% sell-off in shares this morning, but it is still in positive territory in FY23.

 

No time to do stock research, but you still want to invest?

Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

Seek revenue guidance cut from A$1.26bn to $1.245bn

Seek’s revenue guidance was only cut by 1.2%, from $1.26bn to $1.245bn. Shares in the company fell by 5% this morning. Despite today’s losses, shares are still up on a YTD basis.

 

Seek (ASX:SEK) share price chart, log scale (Source: TradingView)

 

An over-reaction?

You could argue this was an over-reaction given that its EBITDA and NPAT guidance was unchanged and reiterated. However, three things may be of concern to investors.

First, it gave a warning that job ad volumes were moderating. The company wasn’t specific beyond that general warning – it did not state the extent to which they were moderating and how long it was expected. Granted, it is clearly not too vehement if Seek’s revenue guidance is only being downgraded by 1%.

Second, the company’s unchanged EBITDA and NPAT guidance was assumed to be offset by lower than assumed operating expenditure. And third, the fact that the company’s guidance was downgraded so soon after it was iterated.

Ultimately, only time will tell if its guidance holds. But investors may be forgiven for being sceptical amidst 4-decade high inflation.

 

 

Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

There’s no credit card needed – the trial expires automatically.

 

 

Recent Posts

Transition Resources

New thinking helps 2025 ASX IPO candidate Transition Resources make new discoveries in Cloncurry

Humble beginnings The resources industry in Australia attracts people with a diverse array of backgrounds, and David Wilson, Managing Director…

4D Medical

4D Medical (ASX:4DX) could become the next Pro Medicus, it’s a long way to the top

There’s not many Australian radiology companies that seek to conquer the USA, but 4D Medical (ASX:4DX) is one of them.…

signs to buy a stock

Pay attention to these 5 signs to buy a stock

What are the most important signs to buy a stock on the ASX or any other stock exchange? In this…